University of Lausanne Hospital
Lausanne, Canton of Vaud, 1010, Switzerland
NCT Number: NCT03714542
The precision of MRI has improved over the past few years, in particular for the hepatobiliary and pancreatic pathologies. The role of MRI in the management of operated pancreas tumors remains nevertheless unclear and few studies have compared MRI to the actual gold standard (CT). Compared to CT, MRI is not only a morphologic imaging technique but also a functional imaging technique. MRI could therefore evaluate in a non-ionizing and dynamic way several important pre- and postoperative aspects after pancreaticoduodenectomy (PD). This study on the perioperative role of MRI includes 3 parts:
First, CT is known to minimize the real size of the pancreatic tumors and to underestimate the vascular invasion correlated to resectability. The preoperative determination of the resection surgical margins could be improved thanks to the high-contrast resolution of MRI.
Moreover, PD is a complex surgery encompassing a fragile anastomosis between the pancreatic parenchyma and the digestive tract. The permeability of the pancreatic anastomosis after PD remains presently unknown and has not been correlated to the clinical state of the patient. MRI associated with secretin injection allows evaluating this permeability, which cannot be done by CT due to the absence of functional evaluation.
Finally, present radiological follow-up after PD for tumors of the pancreatic head is performed with CT. The MRI performance has not been demonstrated yet in the context of follow-up. This imaging modality nevertheless offers unique specificities that are very interesting and that could be helpful for the diagnosis of recurrence.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Lausanne, Canton of Vaud, 1010, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Preoperative MRI performed up to one month before the operation date.
The preoperative MRI results will be compared to the anatomopathological results.
Time frame: Preoperative MRI performed up to one month before the operation date.
The preoperative MRI results will be compared to the anatomopathological results. Tumor size and resection margins will be measured in cm.
Time frame: One year after the operation
MRI with secretin injection
Time frame: One year after the operation
Elastase test in the stool
Time frame: One year after the operation
Anastomosis non-permeability will be assessed with MRI with secretin one year after the operation. A score of permeability (number) will be appointed to determine permeability or not. Exocrine insufficiency will be defined by stool elastase measure <200 ug/g one year after the operation.
Time frame: One year after the operation
Time frame: One year after the operation
Comparison to the CT-scan
University of Lausanne Hospitals
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06842303
Pancreas Adenocarcinomas
Vandœuvre-lès-Nancy, France
View Trial Details